Prusov Evgeny V
Helmholtz Zentrum für Infektionsforschung, Braunschweig, Germany.
Curr Pharm Des. 2016;22(12):1730-55. doi: 10.2174/1381612822666160115130633.
Efficient control of the infectious diseases in the era of the emerging bacterial resistance demands consistent development of new antibiotic agents with novel modes of action. With some notable exceptions, the majority of the currently used antibiotics are natural product-derived compounds which were elaborated upon lead structures discovered by screening of various isolates. In this review, we summarized some selected examples of recent advances in the area of natural product based antibiotic development with particular emphasis on the synthetic and SAR-elucidation aspects.
在新出现的细菌耐药性时代,要有效控制传染病,就需要持续开发具有新型作用模式的新型抗生素。除了一些显著的例外情况,目前使用的大多数抗生素都是天然产物衍生化合物,这些化合物是在对各种分离物进行筛选发现的先导结构基础上进行优化的。在本综述中,我们总结了基于天然产物的抗生素开发领域近期进展的一些精选实例,特别强调了合成和构效关系阐明方面。